RxDoctor Payments Data

Jennifer Macswords, DO

Family Medicine · Milford, OHNPI 1336625680

Payments from drug & device makers

$349in general payments, 2019–2025

Across 13 payments — averaging $26.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$124
  • AbbVie$63
  • Exact Sciences$48
  • Bayer$27
  • Novo Nordisk$24
  • Boehringer Ingelheim$17
  • plus $46 from 3 others

What the payments were for

  • Food & beverage$349100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$349 in reported general payments places this provider in the 45th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$42,782
Medicare patients
198
Services billed
577

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin28$27,342
EliquisApixaban31$26,201
JanuviaSitagliptin Phosphate15$15,155
FarxigaDapagliflozin Propanediol12$8,532
Albuterol Sulfate HfaAlbuterol Sulfate75$2,124
Atorvastatin Calcium140$1,083
Duloxetine Hcl33$1,035
Gabapentin76$890
Pantoprazole Sodium67$785
Losartan Potassium71$715
Omeprazole60$646
Lisinopril106$597
Metoprolol Succinate48$580
Levothyroxine Sodium84$546
Escitalopram Oxalate28$543

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$17$27,34228 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Milford

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →